Skip to main content
. 2011 Nov 4;6(11):e26305. doi: 10.1371/journal.pone.0026305

Table 3. Proportion of subjects seropositive for antibodies to MSP-119 by background characteristics of participants, season and type of survey.

Variables Wet season sero-positives,% (95%CI) Dry season sero-positives,% (95%CI)
Community Health centre Community Health centre
Gender
Males 18.9 (16.9,20.8) 29.0 (26.6,31.4) 18.9 (16.9,20.8) 14.3 (12.4,16.2)
Females 22.7 (20.8,24.6) 36.1 (33.9,38.2) 22.9 (21.0,24.9) 25.3 (23.4,27.2)
Fever
Yes 21.5 (15.8,28.1) 36.6 (33.6,39.6) 11.3 (4.9,21.0) 14.6 (11.9,17.6)
No 20.9 (19.5,22.3) 31.6 (29.7,33.5) 21.2 (19.8,22.6) 22.1 (20.5,23.6)
Patent Parasitaemia
Yes 33.4 (29.0,37.7) 54.8 (51.6,57.9) 33.3 (22.8,43.8) 33.3 (18.9,51.6)
No 19.1 (17.6, 20.4) 24.7 (23.0,26.4) 20.7 (19.3,22.1) 20.6 (19.2,21.9)
Gametocytaemia
Yes 40.7 (27.5,53.9) 70.0 (57.1,82.8) 28.6 (0.0, 64.7) 33.3 (0.0,98.6)
No 20.6 (19.2,21.9) 32.6 (31.0,34.1) 21.0 (19.6,22.4) 20.7 (19.3,22.0)
Slept under a bednet
Yes 20.6 (19.1,22.0) 31.0 (29.2,32.70 19.8 (18.2,21.3) 19.0 (17.4,20.6)
No 22.8 (19.0,26.5) 40.7 (37.1,44.2) 25.4 (22.2,28.5) 24.4 (21.8,27.0)
Ethnic groups
Fula 27.6 (24.7,30.6) 44.8 (41.8,47.8) 29.7 (26.8,32.7) 33.5 (30.7,36.5)
Wolof 18.8 (14.1,23.9) 38.2 (33.2,43.2) 19.5 (14.8,24.9) 16.2 (12.3,20.6)
Mandinka 19.0 (17.3,20.8) 26.3 (23.9,28.7) 17.0 (15.3,18.7) 14.0 (12.2,16.0)
Others 15.2 (11.1,19.8) 24.7 (21.3,28.2) 19.9 (15.5,24.7) 17.1 (14.4,20.1)